InsurTechs hunt for their ‘Ozempic moment': Key takeaways from Insurtech Insights
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

InsurTechs hunt for their ‘Ozempic moment': Key takeaways from Insurtech Insights

insurtech insights main.jpg

In America, there are several weight/health management companies, with the present market size close to $150bn and expected to reach $300bn by 2030. WeightWatchers is a key participant in the marketplace and its pitch has always been essentially something like: eat your broccoli, count your food points and exercise. That has pretty much remained the message for decades. Until now.

In 2021, weight loss drugs Ozempic and Wegovy were approved for diabetes, and soon doctors started prescribing them. Things progressed and several internet pharmacies are now willing to dole out these medicines without much oversight.

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Gift this article